FGP
MRK icon

Foyston, Gordon, & Payne’s Merck MRK Stock Holding History

Foyston, Gordon, & Payne’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-38,204
Closed -$2.21M – 62
2018
Q2 		$2.21M Sell
38,204
-37,256
-49% -$2.1M 0.41% 45
2018
Q1 		$3.92M Sell
75,460
-3,061
-4% -$165K 0.76% 33
2017
Q4 		$4.22M Sell
78,521
-3,675
-4% -$204K 0.8% 35
2017
Q3 		$5.02M Sell
82,196
-909
-1% -$55.1K 0.87% 30
2017
Q2 		$5.08M Sell
83,105
-654
-0.8% -$39.8K 1.1% 28
2017
Q1 		$5.08M Buy
83,759
+1,380
+2% +$83.7K 1.1% 29
2016
Q4 		$4.63M Sell
82,379
-38,913
-32% -$2.28M 1.1% 30
2016
Q3 		$7.22M Sell
121,292
-34,989
-22% -$2.05M 1.39% 26
2016
Q2 		$8.59M Sell
156,281
-853
-0.5% -$45.4K 1.57% 22
2016
Q1 		$7.93M Buy
157,134
+12,283
+8% +$602K 1.48% 27
2015
Q4 		$7.3M Sell
144,851
-8,175
-5% -$412K 1.38% 27
2015
Q3 		$7.21M Buy
153,026
+8,258
+6% +$439K 1.34% 33
2015
Q2 		$7.86M Sell
144,768
-7,666
-5% -$430K 1.18% 33
2015
Q1 		$8.36M Sell
152,434
-16,411
-10% -$929K 1.23% 30
2014
Q4 		$9.15M Buy
168,845
+356
+0.2% +$19.8K 1.31% 30
2014
Q3 		$9.53M Sell
168,489
-15,269
-8% -$857K 1.37% 29
2014
Q2 		$10.1M Sell
183,758
-50,409
-22% -$2.75M 1.29% 31
2014
Q1 		$12.7M Sell
234,167
-56,956
-20% -$2.95M 1.56% 28
2013
Q4 		$13.9M Buy
291,123
+29,239
+11% +$1.34M 1.73% 23
2013
Q3 		$11.9M Sell
261,884
-48,176
-16% -$2.2M 1.55% 26
2013
Q2 		$13.7M Buy
+310,060
New +$13.8M 2.05% 19

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Foyston, Gordon, & Payne's MRK Position: Q3 2018 in Review

Foyston, Gordon, & Payne sold out of Merck (MRK) in Q3 2018, closing a stake of 38,204 shares — an estimated $2.21M sold.

Foyston, Gordon, & Payne first reported a position in MRK in Q2 2013 and held it in 21 quarters. The position peaked at $13.9M in Q4 2013. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Foyston, Gordon, & Payne reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 38,204 Merck shares in Q3 2018, an estimated $2.21M.
  • Foyston, Gordon, & Payne first reported a position in Merck in Q2 2013 and held it in 21 quarters.
  • Foyston, Gordon, & Payne's Merck position peaked at $13.9M in Q4 2013.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2018, filed 2 Nov 2018.